/ Evidence licensing
The evidence layer, licensed.
Telehealth platforms and clinics need compound reference content their compliance team can sign off on. Ours is built for exactly that: every entry keyed to resolved public identifiers, regulatory status stated plainly, citations attached and machine re-checked against the registries they point into.
What you license
The compound library as structured data or rendered content: summaries, regulatory status, half-life pharmacology, handling, and citations with their identifiers.
Why it holds up
Citations stay visible, so a clinician can review the basis of every statement. That transparency is also what keeps reference software on the right side of FDA device rules.
What it never does
No dosing recommendations, anywhere, in any licensed use. And licensed content may not be reused as marketing for compound sales; that clause protects you as much as us.
/ The terms, in plain words
Flat licensing fees, scoped by use.
Citations and identifiers ship with the content.
No promotional reuse for the sale of unapproved compounds.